XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock and paid-in capital
Treasury stock, at cost
Accumulated earnings (deficit)
Accumulated other comprehensive income (loss)
Balance, beginning of period at Dec. 31, 2022   $ 819,120 $ 0 $ 17,335 $ (10,882)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercise of equity awards   1,315      
Issuance of common stock related to 365 Pronto, Inc. post combination expense   10,307      
Payment of withholding taxes related to net share settlement of equity awards   (93,100)      
Settlement of convertible notes due 2023   5,000      
Stock-based compensation expense   156,466      
Purchases of treasury stock, at cost     (68,140)    
Treasury stock retired and reclassed to accumulated earnings     68,140 (68,140)  
Repurchase of common stock $ (310,000)     (241,860)  
Net income 418,017     418,017  
Foreign currency translation adjustments (2,234)       (2,234)
Change in net unrealized gain on marketable securities, net of tax         3,354
Balance, end of period at Sep. 30, 2023 1,014,698 899,108 0 125,352 (9,762)
Balance, beginning of period at Jun. 30, 2023   858,040 68,140 189,539 (6,852)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercise of equity awards   719      
Payment of withholding taxes related to net share settlement of equity awards   (8,465)      
Settlement of convertible notes due 2023   5,000      
Stock-based compensation expense   43,814      
Purchases of treasury stock, at cost     0    
Treasury stock retired and reclassed to accumulated earnings     68,140 (68,140)  
Repurchase of common stock (110,000)     (110,000)  
Net income 113,953     113,953  
Foreign currency translation adjustments (3,742)       (3,742)
Change in net unrealized gain on marketable securities, net of tax         832
Balance, end of period at Sep. 30, 2023 1,014,698 899,108 0 125,352 (9,762)
Balance, beginning of period at Dec. 31, 2023 983,624 939,339 0 46,273 (1,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercise of equity awards   7,969      
Payment of withholding taxes related to net share settlement of equity awards   (73,801)      
Settlement of convertible notes due 2023   0      
Stock-based compensation expense   159,530      
Repurchase of common stock (191,700)     (191,698)  
Net income 40,498     40,498  
Foreign currency translation adjustments 698       698
Change in net unrealized gain on marketable securities, net of tax         4,553
Balance, end of period at Sep. 30, 2024 931,373 1,033,037 0 (104,927) 3,263
Balance, beginning of period at Jun. 30, 2024   993,369 0 (100,895) (7,951)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercise of equity awards   14      
Payment of withholding taxes related to net share settlement of equity awards   (6,286)      
Settlement of convertible notes due 2023   0      
Stock-based compensation expense   45,940      
Repurchase of common stock (49,800)     (49,794)  
Net income 45,762     45,762  
Foreign currency translation adjustments 4,356       4,356
Change in net unrealized gain on marketable securities, net of tax         6,858
Balance, end of period at Sep. 30, 2024 $ 931,373 $ 1,033,037 $ 0 $ (104,927) $ 3,263